Giovanni Benedetti

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

Alfredo Falcone, Sergio Ricci, I. Brunetti et al. · Journal of Clinical Oncology · 2007 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +12

Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status

Matteo Lambertini, Niels Kroman, Lieveke Ameye et al. · JNCI Journal of the National Cancer Institute · 2017 · 178 citations · Full text

Medicine, Obstetrics, Oncology +15

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

Xavier Pivot, Andreas Schneeweiß, Shailendra Verma et al. · European Journal of Cancer · 2011 · 110 citations

Medicine, Oncology, Pharmacotherapy +9

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices

Ying Chen, Thomas J.W. Sharples, Keith G. Phillips et al. · Neuropharmacology · 2003 · 45 citations

Life Sciences, Neuroscience, Pharmacology +17